Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026)
Voyager Therapeutics (VYGR) EBT Margin Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,237.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -120.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -115,976.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115,976.00 |
| Dec 31, 2025 | -170,156.00 |
| Sep 30, 2025 | -25,097.00 |
| Jun 30, 2025 | 203,909.00 |
| Mar 31, 2025 | 276,130.00 |
| Dec 31, 2024 | -17,518.00 |
| Sep 30, 2024 | 561,372.00 |
| Jun 30, 2024 | 311,347.00 |
| Mar 31, 2024 | 128,578.00 |
| Dec 31, 2023 | 172,587.00 |
| Sep 30, 2023 | -60,165.00 |
| Jun 30, 2023 | -38,402.00 |
| Mar 31, 2023 | 25,235.00 |
| Dec 31, 2022 | 156,171.00 |
| Sep 30, 2022 | 11,634.00 |
| Jun 30, 2022 | -270,496.00 |
| Mar 31, 2022 | -271,717.00 |
| Dec 31, 2021 | 75,918.00 |
| Sep 30, 2021 | -468,136.00 |
| Jun 30, 2021 | -215,580.00 |